Stock PBYI PUMA BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Puma Biotechnology, Inc.

Equities

PBYI

US74587V1070

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
4.83 USD -5.85% Intraday chart for Puma Biotechnology, Inc. -6.58% +11.55%
Mar. 20 Puma Biotechnology Plans to Start Breast Cancer Combination Study in Second Half; Shares Rise MT
Mar. 20 Puma Biotechnology, Inc. Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Lowers Price Target on Puma Biotechnology Inc to $8 From $12, Reiterates Buy Rating
MT
PUMA BIOTECHNOLOGY : Citigroup Upgrades Puma Biotechnology to Buy From Neutral, Price Target at $11
MT
PUMA BIOTECHNOLOGY : RBC Cuts PT on Puma Biotechnology to $6 From $13, Citing Nerlynx 2021 Sales Estimates; Sector Perform-Speculative Risk Rating Kept
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PBYI Stock
  4. News Puma Biotechnology, Inc.
  5. Analyst Reco.